Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Malignant Tumors × regorafenib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 4 Solid Malignant Tumors 1 Recurrence 1 Rectal Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Glioblastoma 1 Disease Progression 1 Colorectal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06246643 2026-04-20

A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies

Bayer

Phase 2 Active not recruiting

Solid Malignant Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡